nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCC1—Epirubicin—urinary bladder cancer	0.0719	0.104	CbGbCtD
Indinavir—ABCB1—Mitomycin—urinary bladder cancer	0.0658	0.0953	CbGbCtD
Indinavir—ABCC1—Etoposide—urinary bladder cancer	0.056	0.0812	CbGbCtD
Indinavir—ABCC2—Carboplatin—urinary bladder cancer	0.0494	0.0716	CbGbCtD
Indinavir—ABCC2—Cisplatin—urinary bladder cancer	0.0422	0.0612	CbGbCtD
Indinavir—ABCC2—Etoposide—urinary bladder cancer	0.0415	0.0601	CbGbCtD
Indinavir—ABCC1—Doxorubicin—urinary bladder cancer	0.0382	0.0554	CbGbCtD
Indinavir—ABCC1—Methotrexate—urinary bladder cancer	0.037	0.0536	CbGbCtD
Indinavir—SLCO1A2—Methotrexate—urinary bladder cancer	0.033	0.0479	CbGbCtD
Indinavir—SLCO1B1—Methotrexate—urinary bladder cancer	0.0312	0.0452	CbGbCtD
Indinavir—CYP3A4—Thiotepa—urinary bladder cancer	0.0299	0.0433	CbGbCtD
Indinavir—ABCC2—Doxorubicin—urinary bladder cancer	0.0283	0.041	CbGbCtD
Indinavir—ABCC2—Methotrexate—urinary bladder cancer	0.0274	0.0397	CbGbCtD
Indinavir—CYP3A5—Etoposide—urinary bladder cancer	0.0208	0.0301	CbGbCtD
Indinavir—ABCB1—Gemcitabine—urinary bladder cancer	0.0189	0.0274	CbGbCtD
Indinavir—CYP2C9—Fluorouracil—urinary bladder cancer	0.0167	0.0242	CbGbCtD
Indinavir—CYP2C9—Cisplatin—urinary bladder cancer	0.0142	0.0205	CbGbCtD
Indinavir—ABCB1—Cisplatin—urinary bladder cancer	0.0138	0.0199	CbGbCtD
Indinavir—ABCB1—Etoposide—urinary bladder cancer	0.0135	0.0196	CbGbCtD
Indinavir—ABCB1—Doxorubicin—urinary bladder cancer	0.00922	0.0134	CbGbCtD
Indinavir—ABCB1—Methotrexate—urinary bladder cancer	0.00893	0.0129	CbGbCtD
Indinavir—CYP2D6—Doxorubicin—urinary bladder cancer	0.00868	0.0126	CbGbCtD
Indinavir—CYP3A4—Etoposide—urinary bladder cancer	0.0081	0.0117	CbGbCtD
Indinavir—CYP3A4—Doxorubicin—urinary bladder cancer	0.00552	0.008	CbGbCtD
Indinavir—CYP2C19—urine—urinary bladder cancer	0.00303	0.111	CbGeAlD
Indinavir—CYP2C9—urine—urinary bladder cancer	0.00235	0.0859	CbGeAlD
Indinavir—CYP3A4—urine—urinary bladder cancer	0.00179	0.0655	CbGeAlD
Indinavir—CYP2D6—urine—urinary bladder cancer	0.00176	0.0645	CbGeAlD
Indinavir—ABCC2—prostate gland—urinary bladder cancer	0.00127	0.0463	CbGeAlD
Indinavir—SLCO1B1—renal system—urinary bladder cancer	0.00114	0.0416	CbGeAlD
Indinavir—ABCC1—prostate gland—urinary bladder cancer	0.00112	0.0408	CbGeAlD
Indinavir—SLC22A1—renal system—urinary bladder cancer	0.000962	0.0352	CbGeAlD
Indinavir—ABCC1—seminal vesicle—urinary bladder cancer	0.000944	0.0345	CbGeAlD
Indinavir—SLCO1A2—renal system—urinary bladder cancer	0.000927	0.0339	CbGeAlD
Indinavir—SLCO1B1—female reproductive system—urinary bladder cancer	0.000912	0.0333	CbGeAlD
Indinavir—ABCC2—renal system—urinary bladder cancer	0.000863	0.0316	CbGeAlD
Indinavir—CYP3A5—prostate gland—urinary bladder cancer	0.000857	0.0313	CbGeAlD
Indinavir—ABCC1—urethra—urinary bladder cancer	0.000747	0.0273	CbGeAlD
Indinavir—SLC22A1—vagina—urinary bladder cancer	0.000697	0.0255	CbGeAlD
Indinavir—ABCC2—female reproductive system—urinary bladder cancer	0.000691	0.0253	CbGeAlD
Indinavir—CYP3A5—renal system—urinary bladder cancer	0.000584	0.0214	CbGeAlD
Indinavir—ABCC1—vagina—urinary bladder cancer	0.000551	0.0201	CbGeAlD
Indinavir—CYP2C19—vagina—urinary bladder cancer	0.000537	0.0196	CbGeAlD
Indinavir—CYP2C9—female reproductive system—urinary bladder cancer	0.000461	0.0168	CbGeAlD
Indinavir—ABCB1—prostate gland—urinary bladder cancer	0.000456	0.0166	CbGeAlD
Indinavir—CYP3A4—renal system—urinary bladder cancer	0.000439	0.016	CbGeAlD
Indinavir—CYP2D6—renal system—urinary bladder cancer	0.000432	0.0158	CbGeAlD
Indinavir—CYP3A5—vagina—urinary bladder cancer	0.000423	0.0155	CbGeAlD
Indinavir—ABCC2—lymph node—urinary bladder cancer	0.000404	0.0148	CbGeAlD
Indinavir—ABCB1—seminal vesicle—urinary bladder cancer	0.000385	0.0141	CbGeAlD
Indinavir—ABCC1—lymph node—urinary bladder cancer	0.000356	0.013	CbGeAlD
Indinavir—CYP3A4—female reproductive system—urinary bladder cancer	0.000351	0.0128	CbGeAlD
Indinavir—CYP2D6—female reproductive system—urinary bladder cancer	0.000346	0.0126	CbGeAlD
Indinavir—ABCB1—epithelium—urinary bladder cancer	0.000335	0.0122	CbGeAlD
Indinavir—ABCB1—renal system—urinary bladder cancer	0.00031	0.0113	CbGeAlD
Indinavir—ABCB1—urethra—urinary bladder cancer	0.000305	0.0111	CbGeAlD
Indinavir—ABCB1—female reproductive system—urinary bladder cancer	0.000249	0.00909	CbGeAlD
Indinavir—ABCB1—vagina—urinary bladder cancer	0.000225	0.00822	CbGeAlD
Indinavir—Sweating—Epirubicin—urinary bladder cancer	0.000153	0.000779	CcSEcCtD
Indinavir—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000153	0.000779	CcSEcCtD
Indinavir—Asthenia—Gemcitabine—urinary bladder cancer	0.000153	0.000777	CcSEcCtD
Indinavir—Haematuria—Epirubicin—urinary bladder cancer	0.000153	0.000775	CcSEcCtD
Indinavir—Pharyngitis—Methotrexate—urinary bladder cancer	0.000152	0.000773	CcSEcCtD
Indinavir—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000152	0.00077	CcSEcCtD
Indinavir—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000151	0.000768	CcSEcCtD
Indinavir—Weight increased—Doxorubicin—urinary bladder cancer	0.000151	0.000767	CcSEcCtD
Indinavir—Pruritus—Gemcitabine—urinary bladder cancer	0.000151	0.000766	CcSEcCtD
Indinavir—Nausea—Thiotepa—urinary bladder cancer	0.000151	0.000764	CcSEcCtD
Indinavir—Urethral disorder—Methotrexate—urinary bladder cancer	0.00015	0.000764	CcSEcCtD
Indinavir—Sinusitis—Epirubicin—urinary bladder cancer	0.00015	0.000762	CcSEcCtD
Indinavir—Feeling abnormal—Etoposide—urinary bladder cancer	0.00015	0.000762	CcSEcCtD
Indinavir—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.00015	0.00076	CcSEcCtD
Indinavir—Pneumonia—Doxorubicin—urinary bladder cancer	0.000149	0.000756	CcSEcCtD
Indinavir—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000149	0.000756	CcSEcCtD
Indinavir—Pruritus—Fluorouracil—urinary bladder cancer	0.000148	0.000753	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000147	0.000745	CcSEcCtD
Indinavir—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000146	0.000743	CcSEcCtD
Indinavir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000146	0.000741	CcSEcCtD
Indinavir—Renal failure—Doxorubicin—urinary bladder cancer	0.000146	0.000739	CcSEcCtD
Indinavir—ABCB1—lymph node—urinary bladder cancer	0.000145	0.00532	CbGeAlD
Indinavir—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000145	0.000737	CcSEcCtD
Indinavir—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000145	0.000737	CcSEcCtD
Indinavir—Urticaria—Etoposide—urinary bladder cancer	0.000145	0.000734	CcSEcCtD
Indinavir—Haemoglobin—Epirubicin—urinary bladder cancer	0.000144	0.000733	CcSEcCtD
Indinavir—Jaundice—Doxorubicin—urinary bladder cancer	0.000144	0.000733	CcSEcCtD
Indinavir—Body temperature increased—Etoposide—urinary bladder cancer	0.000144	0.000731	CcSEcCtD
Indinavir—Abdominal pain—Etoposide—urinary bladder cancer	0.000144	0.000731	CcSEcCtD
Indinavir—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000144	0.000731	CcSEcCtD
Indinavir—Hepatitis—Epirubicin—urinary bladder cancer	0.000144	0.000729	CcSEcCtD
Indinavir—Haemorrhage—Epirubicin—urinary bladder cancer	0.000144	0.000729	CcSEcCtD
Indinavir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000143	0.000728	CcSEcCtD
Indinavir—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000143	0.000726	CcSEcCtD
Indinavir—Asthenia—Cisplatin—urinary bladder cancer	0.000143	0.000724	CcSEcCtD
Indinavir—Pharyngitis—Epirubicin—urinary bladder cancer	0.000143	0.000724	CcSEcCtD
Indinavir—Sweating—Doxorubicin—urinary bladder cancer	0.000142	0.000721	CcSEcCtD
Indinavir—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000142	0.00072	CcSEcCtD
Indinavir—Haematuria—Doxorubicin—urinary bladder cancer	0.000141	0.000717	CcSEcCtD
Indinavir—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000141	0.000717	CcSEcCtD
Indinavir—Urethral disorder—Epirubicin—urinary bladder cancer	0.000141	0.000715	CcSEcCtD
Indinavir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00014	0.000711	CcSEcCtD
Indinavir—Sinusitis—Doxorubicin—urinary bladder cancer	0.000139	0.000705	CcSEcCtD
Indinavir—Immune system disorder—Methotrexate—urinary bladder cancer	0.000139	0.000704	CcSEcCtD
Indinavir—Dizziness—Fluorouracil—urinary bladder cancer	0.000139	0.000704	CcSEcCtD
Indinavir—Chills—Methotrexate—urinary bladder cancer	0.000138	0.000699	CcSEcCtD
Indinavir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000136	0.00069	CcSEcCtD
Indinavir—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000136	0.00069	CcSEcCtD
Indinavir—Alopecia—Methotrexate—urinary bladder cancer	0.000136	0.000689	CcSEcCtD
Indinavir—Vomiting—Gemcitabine—urinary bladder cancer	0.000136	0.000688	CcSEcCtD
Indinavir—Rash—Gemcitabine—urinary bladder cancer	0.000134	0.000683	CcSEcCtD
Indinavir—Dermatitis—Gemcitabine—urinary bladder cancer	0.000134	0.000682	CcSEcCtD
Indinavir—Hypersensitivity—Etoposide—urinary bladder cancer	0.000134	0.000681	CcSEcCtD
Indinavir—Malnutrition—Methotrexate—urinary bladder cancer	0.000134	0.000678	CcSEcCtD
Indinavir—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000134	0.000678	CcSEcCtD
Indinavir—Headache—Gemcitabine—urinary bladder cancer	0.000134	0.000678	CcSEcCtD
Indinavir—Flushing—Epirubicin—urinary bladder cancer	0.000133	0.000677	CcSEcCtD
Indinavir—Vomiting—Fluorouracil—urinary bladder cancer	0.000133	0.000677	CcSEcCtD
Indinavir—Hepatitis—Doxorubicin—urinary bladder cancer	0.000133	0.000675	CcSEcCtD
Indinavir—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000133	0.000675	CcSEcCtD
Indinavir—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000132	0.000671	CcSEcCtD
Indinavir—Rash—Fluorouracil—urinary bladder cancer	0.000132	0.000671	CcSEcCtD
Indinavir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000132	0.00067	CcSEcCtD
Indinavir—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000132	0.00067	CcSEcCtD
Indinavir—Headache—Fluorouracil—urinary bladder cancer	0.000131	0.000667	CcSEcCtD
Indinavir—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000131	0.000666	CcSEcCtD
Indinavir—Dysgeusia—Methotrexate—urinary bladder cancer	0.000131	0.000664	CcSEcCtD
Indinavir—Asthenia—Etoposide—urinary bladder cancer	0.000131	0.000663	CcSEcCtD
Indinavir—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000131	0.000663	CcSEcCtD
Indinavir—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00013	0.000661	CcSEcCtD
Indinavir—Immune system disorder—Epirubicin—urinary bladder cancer	0.00013	0.000659	CcSEcCtD
Indinavir—Back pain—Methotrexate—urinary bladder cancer	0.000129	0.000656	CcSEcCtD
Indinavir—Chills—Epirubicin—urinary bladder cancer	0.000129	0.000654	CcSEcCtD
Indinavir—Pruritus—Etoposide—urinary bladder cancer	0.000129	0.000654	CcSEcCtD
Indinavir—Alopecia—Epirubicin—urinary bladder cancer	0.000127	0.000644	CcSEcCtD
Indinavir—Nausea—Gemcitabine—urinary bladder cancer	0.000127	0.000643	CcSEcCtD
Indinavir—Vomiting—Cisplatin—urinary bladder cancer	0.000126	0.000642	CcSEcCtD
Indinavir—Vision blurred—Methotrexate—urinary bladder cancer	0.000126	0.000639	CcSEcCtD
Indinavir—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000126	0.000638	CcSEcCtD
Indinavir—Rash—Cisplatin—urinary bladder cancer	0.000125	0.000636	CcSEcCtD
Indinavir—Dermatitis—Cisplatin—urinary bladder cancer	0.000125	0.000636	CcSEcCtD
Indinavir—Malnutrition—Epirubicin—urinary bladder cancer	0.000125	0.000635	CcSEcCtD
Indinavir—Diarrhoea—Etoposide—urinary bladder cancer	0.000125	0.000632	CcSEcCtD
Indinavir—Nausea—Fluorouracil—urinary bladder cancer	0.000125	0.000632	CcSEcCtD
Indinavir—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000124	0.000629	CcSEcCtD
Indinavir—Anaemia—Methotrexate—urinary bladder cancer	0.000123	0.000627	CcSEcCtD
Indinavir—Flushing—Doxorubicin—urinary bladder cancer	0.000123	0.000626	CcSEcCtD
Indinavir—Flatulence—Epirubicin—urinary bladder cancer	0.000123	0.000626	CcSEcCtD
Indinavir—Tension—Epirubicin—urinary bladder cancer	0.000123	0.000623	CcSEcCtD
Indinavir—Dysgeusia—Epirubicin—urinary bladder cancer	0.000122	0.000622	CcSEcCtD
Indinavir—Nervousness—Epirubicin—urinary bladder cancer	0.000121	0.000617	CcSEcCtD
Indinavir—Back pain—Epirubicin—urinary bladder cancer	0.000121	0.000614	CcSEcCtD
Indinavir—Malaise—Methotrexate—urinary bladder cancer	0.00012	0.000612	CcSEcCtD
Indinavir—Dizziness—Etoposide—urinary bladder cancer	0.00012	0.000611	CcSEcCtD
Indinavir—Muscle spasms—Epirubicin—urinary bladder cancer	0.00012	0.00061	CcSEcCtD
Indinavir—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00012	0.00061	CcSEcCtD
Indinavir—Vertigo—Methotrexate—urinary bladder cancer	0.00012	0.000609	CcSEcCtD
Indinavir—Chills—Doxorubicin—urinary bladder cancer	0.000119	0.000605	CcSEcCtD
Indinavir—Nausea—Cisplatin—urinary bladder cancer	0.000118	0.000599	CcSEcCtD
Indinavir—Vision blurred—Epirubicin—urinary bladder cancer	0.000118	0.000598	CcSEcCtD
Indinavir—Alopecia—Doxorubicin—urinary bladder cancer	0.000117	0.000596	CcSEcCtD
Indinavir—Cough—Methotrexate—urinary bladder cancer	0.000117	0.000592	CcSEcCtD
Indinavir—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000116	0.000589	CcSEcCtD
Indinavir—Vomiting—Etoposide—urinary bladder cancer	0.000116	0.000588	CcSEcCtD
Indinavir—Malnutrition—Doxorubicin—urinary bladder cancer	0.000116	0.000587	CcSEcCtD
Indinavir—Anaemia—Epirubicin—urinary bladder cancer	0.000116	0.000587	CcSEcCtD
Indinavir—Agitation—Epirubicin—urinary bladder cancer	0.000115	0.000583	CcSEcCtD
Indinavir—Rash—Etoposide—urinary bladder cancer	0.000115	0.000583	CcSEcCtD
Indinavir—Dermatitis—Etoposide—urinary bladder cancer	0.000115	0.000582	CcSEcCtD
Indinavir—Headache—Etoposide—urinary bladder cancer	0.000114	0.000579	CcSEcCtD
Indinavir—Flatulence—Doxorubicin—urinary bladder cancer	0.000114	0.000579	CcSEcCtD
Indinavir—Myalgia—Methotrexate—urinary bladder cancer	0.000114	0.000578	CcSEcCtD
Indinavir—Chest pain—Methotrexate—urinary bladder cancer	0.000114	0.000578	CcSEcCtD
Indinavir—Arthralgia—Methotrexate—urinary bladder cancer	0.000114	0.000578	CcSEcCtD
Indinavir—Tension—Doxorubicin—urinary bladder cancer	0.000114	0.000576	CcSEcCtD
Indinavir—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000113	0.000575	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000113	0.000574	CcSEcCtD
Indinavir—Malaise—Epirubicin—urinary bladder cancer	0.000113	0.000573	CcSEcCtD
Indinavir—Discomfort—Methotrexate—urinary bladder cancer	0.000112	0.000571	CcSEcCtD
Indinavir—Nervousness—Doxorubicin—urinary bladder cancer	0.000112	0.000571	CcSEcCtD
Indinavir—Vertigo—Epirubicin—urinary bladder cancer	0.000112	0.00057	CcSEcCtD
Indinavir—Syncope—Epirubicin—urinary bladder cancer	0.000112	0.000569	CcSEcCtD
Indinavir—Back pain—Doxorubicin—urinary bladder cancer	0.000112	0.000568	CcSEcCtD
Indinavir—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000111	0.000565	CcSEcCtD
Indinavir—Palpitations—Epirubicin—urinary bladder cancer	0.00011	0.000561	CcSEcCtD
Indinavir—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00011	0.000558	CcSEcCtD
Indinavir—Cough—Epirubicin—urinary bladder cancer	0.000109	0.000554	CcSEcCtD
Indinavir—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000109	0.000554	CcSEcCtD
Indinavir—Vision blurred—Doxorubicin—urinary bladder cancer	0.000109	0.000554	CcSEcCtD
Indinavir—Nausea—Etoposide—urinary bladder cancer	0.000108	0.000549	CcSEcCtD
Indinavir—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000107	0.000545	CcSEcCtD
Indinavir—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000107	0.000543	CcSEcCtD
Indinavir—Anaemia—Doxorubicin—urinary bladder cancer	0.000107	0.000543	CcSEcCtD
Indinavir—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000107	0.000542	CcSEcCtD
Indinavir—Chest pain—Epirubicin—urinary bladder cancer	0.000106	0.00054	CcSEcCtD
Indinavir—Myalgia—Epirubicin—urinary bladder cancer	0.000106	0.00054	CcSEcCtD
Indinavir—Arthralgia—Epirubicin—urinary bladder cancer	0.000106	0.00054	CcSEcCtD
Indinavir—Agitation—Doxorubicin—urinary bladder cancer	0.000106	0.00054	CcSEcCtD
Indinavir—Anxiety—Epirubicin—urinary bladder cancer	0.000106	0.000539	CcSEcCtD
Indinavir—Skin disorder—Methotrexate—urinary bladder cancer	0.000106	0.000538	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000106	0.000537	CcSEcCtD
Indinavir—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000105	0.000535	CcSEcCtD
Indinavir—Discomfort—Epirubicin—urinary bladder cancer	0.000105	0.000534	CcSEcCtD
Indinavir—Malaise—Doxorubicin—urinary bladder cancer	0.000104	0.00053	CcSEcCtD
Indinavir—Dry mouth—Epirubicin—urinary bladder cancer	0.000104	0.000529	CcSEcCtD
Indinavir—Vertigo—Doxorubicin—urinary bladder cancer	0.000104	0.000528	CcSEcCtD
Indinavir—Anorexia—Methotrexate—urinary bladder cancer	0.000104	0.000528	CcSEcCtD
Indinavir—Syncope—Doxorubicin—urinary bladder cancer	0.000104	0.000527	CcSEcCtD
Indinavir—Palpitations—Doxorubicin—urinary bladder cancer	0.000102	0.000519	CcSEcCtD
Indinavir—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000102	0.000518	CcSEcCtD
Indinavir—Oedema—Epirubicin—urinary bladder cancer	0.000102	0.000518	CcSEcCtD
Indinavir—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000102	0.000516	CcSEcCtD
Indinavir—Cough—Doxorubicin—urinary bladder cancer	0.000101	0.000513	CcSEcCtD
Indinavir—Shock—Epirubicin—urinary bladder cancer	0.0001	0.00051	CcSEcCtD
Indinavir—Nervous system disorder—Epirubicin—urinary bladder cancer	0.0001	0.000508	CcSEcCtD
Indinavir—Thrombocytopenia—Epirubicin—urinary bladder cancer	9.99e-05	0.000507	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	9.93e-05	0.000504	CcSEcCtD
Indinavir—Skin disorder—Epirubicin—urinary bladder cancer	9.91e-05	0.000503	CcSEcCtD
Indinavir—Hyperhidrosis—Epirubicin—urinary bladder cancer	9.86e-05	0.000501	CcSEcCtD
Indinavir—Insomnia—Methotrexate—urinary bladder cancer	9.86e-05	0.000501	CcSEcCtD
Indinavir—Myalgia—Doxorubicin—urinary bladder cancer	9.85e-05	0.0005	CcSEcCtD
Indinavir—Arthralgia—Doxorubicin—urinary bladder cancer	9.85e-05	0.0005	CcSEcCtD
Indinavir—Chest pain—Doxorubicin—urinary bladder cancer	9.85e-05	0.0005	CcSEcCtD
Indinavir—Anxiety—Doxorubicin—urinary bladder cancer	9.82e-05	0.000498	CcSEcCtD
Indinavir—Paraesthesia—Methotrexate—urinary bladder cancer	9.79e-05	0.000497	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	9.78e-05	0.000497	CcSEcCtD
Indinavir—Discomfort—Doxorubicin—urinary bladder cancer	9.73e-05	0.000494	CcSEcCtD
Indinavir—Anorexia—Epirubicin—urinary bladder cancer	9.73e-05	0.000494	CcSEcCtD
Indinavir—Dyspnoea—Methotrexate—urinary bladder cancer	9.72e-05	0.000494	CcSEcCtD
Indinavir—Somnolence—Methotrexate—urinary bladder cancer	9.69e-05	0.000492	CcSEcCtD
Indinavir—Dry mouth—Doxorubicin—urinary bladder cancer	9.63e-05	0.000489	CcSEcCtD
Indinavir—Dyspepsia—Methotrexate—urinary bladder cancer	9.6e-05	0.000487	CcSEcCtD
Indinavir—Decreased appetite—Methotrexate—urinary bladder cancer	9.48e-05	0.000481	CcSEcCtD
Indinavir—Oedema—Doxorubicin—urinary bladder cancer	9.44e-05	0.000479	CcSEcCtD
Indinavir—Anaphylactic shock—Doxorubicin—urinary bladder cancer	9.44e-05	0.000479	CcSEcCtD
Indinavir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	9.41e-05	0.000478	CcSEcCtD
Indinavir—Fatigue—Methotrexate—urinary bladder cancer	9.4e-05	0.000477	CcSEcCtD
Indinavir—Pain—Methotrexate—urinary bladder cancer	9.32e-05	0.000473	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	9.3e-05	0.000472	CcSEcCtD
Indinavir—Shock—Doxorubicin—urinary bladder cancer	9.29e-05	0.000472	CcSEcCtD
Indinavir—Nervous system disorder—Doxorubicin—urinary bladder cancer	9.26e-05	0.00047	CcSEcCtD
Indinavir—Thrombocytopenia—Doxorubicin—urinary bladder cancer	9.24e-05	0.000469	CcSEcCtD
Indinavir—Insomnia—Epirubicin—urinary bladder cancer	9.23e-05	0.000469	CcSEcCtD
Indinavir—Skin disorder—Doxorubicin—urinary bladder cancer	9.17e-05	0.000466	CcSEcCtD
Indinavir—Paraesthesia—Epirubicin—urinary bladder cancer	9.16e-05	0.000465	CcSEcCtD
Indinavir—Hyperhidrosis—Doxorubicin—urinary bladder cancer	9.13e-05	0.000463	CcSEcCtD
Indinavir—Dyspnoea—Epirubicin—urinary bladder cancer	9.1e-05	0.000462	CcSEcCtD
Indinavir—Somnolence—Epirubicin—urinary bladder cancer	9.07e-05	0.000461	CcSEcCtD
Indinavir—Anorexia—Doxorubicin—urinary bladder cancer	9e-05	0.000457	CcSEcCtD
Indinavir—Feeling abnormal—Methotrexate—urinary bladder cancer	8.99e-05	0.000456	CcSEcCtD
Indinavir—Dyspepsia—Epirubicin—urinary bladder cancer	8.98e-05	0.000456	CcSEcCtD
Indinavir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	8.92e-05	0.000453	CcSEcCtD
Indinavir—Decreased appetite—Epirubicin—urinary bladder cancer	8.87e-05	0.00045	CcSEcCtD
Indinavir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	8.81e-05	0.000447	CcSEcCtD
Indinavir—Fatigue—Epirubicin—urinary bladder cancer	8.8e-05	0.000447	CcSEcCtD
Indinavir—Pain—Epirubicin—urinary bladder cancer	8.73e-05	0.000443	CcSEcCtD
Indinavir—Constipation—Epirubicin—urinary bladder cancer	8.73e-05	0.000443	CcSEcCtD
Indinavir—Urticaria—Methotrexate—urinary bladder cancer	8.66e-05	0.00044	CcSEcCtD
Indinavir—Abdominal pain—Methotrexate—urinary bladder cancer	8.62e-05	0.000438	CcSEcCtD
Indinavir—Body temperature increased—Methotrexate—urinary bladder cancer	8.62e-05	0.000438	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	8.6e-05	0.000437	CcSEcCtD
Indinavir—Insomnia—Doxorubicin—urinary bladder cancer	8.54e-05	0.000434	CcSEcCtD
Indinavir—Paraesthesia—Doxorubicin—urinary bladder cancer	8.48e-05	0.00043	CcSEcCtD
Indinavir—Dyspnoea—Doxorubicin—urinary bladder cancer	8.42e-05	0.000427	CcSEcCtD
Indinavir—Feeling abnormal—Epirubicin—urinary bladder cancer	8.41e-05	0.000427	CcSEcCtD
Indinavir—Somnolence—Doxorubicin—urinary bladder cancer	8.39e-05	0.000426	CcSEcCtD
Indinavir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	8.34e-05	0.000424	CcSEcCtD
Indinavir—Dyspepsia—Doxorubicin—urinary bladder cancer	8.31e-05	0.000422	CcSEcCtD
Indinavir—Decreased appetite—Doxorubicin—urinary bladder cancer	8.21e-05	0.000417	CcSEcCtD
Indinavir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	8.15e-05	0.000414	CcSEcCtD
Indinavir—Fatigue—Doxorubicin—urinary bladder cancer	8.14e-05	0.000413	CcSEcCtD
Indinavir—Urticaria—Epirubicin—urinary bladder cancer	8.11e-05	0.000412	CcSEcCtD
Indinavir—Pain—Doxorubicin—urinary bladder cancer	8.07e-05	0.00041	CcSEcCtD
Indinavir—Constipation—Doxorubicin—urinary bladder cancer	8.07e-05	0.00041	CcSEcCtD
Indinavir—Abdominal pain—Epirubicin—urinary bladder cancer	8.07e-05	0.00041	CcSEcCtD
Indinavir—Body temperature increased—Epirubicin—urinary bladder cancer	8.07e-05	0.00041	CcSEcCtD
Indinavir—Hypersensitivity—Methotrexate—urinary bladder cancer	8.03e-05	0.000408	CcSEcCtD
Indinavir—Asthenia—Methotrexate—urinary bladder cancer	7.82e-05	0.000397	CcSEcCtD
Indinavir—Feeling abnormal—Doxorubicin—urinary bladder cancer	7.78e-05	0.000395	CcSEcCtD
Indinavir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	7.72e-05	0.000392	CcSEcCtD
Indinavir—Pruritus—Methotrexate—urinary bladder cancer	7.71e-05	0.000392	CcSEcCtD
Indinavir—Hypersensitivity—Epirubicin—urinary bladder cancer	7.52e-05	0.000382	CcSEcCtD
Indinavir—Urticaria—Doxorubicin—urinary bladder cancer	7.5e-05	0.000381	CcSEcCtD
Indinavir—Abdominal pain—Doxorubicin—urinary bladder cancer	7.46e-05	0.000379	CcSEcCtD
Indinavir—Body temperature increased—Doxorubicin—urinary bladder cancer	7.46e-05	0.000379	CcSEcCtD
Indinavir—Diarrhoea—Methotrexate—urinary bladder cancer	7.46e-05	0.000379	CcSEcCtD
Indinavir—Asthenia—Epirubicin—urinary bladder cancer	7.32e-05	0.000372	CcSEcCtD
Indinavir—Pruritus—Epirubicin—urinary bladder cancer	7.22e-05	0.000367	CcSEcCtD
Indinavir—Dizziness—Methotrexate—urinary bladder cancer	7.21e-05	0.000366	CcSEcCtD
Indinavir—Diarrhoea—Epirubicin—urinary bladder cancer	6.98e-05	0.000355	CcSEcCtD
Indinavir—Hypersensitivity—Doxorubicin—urinary bladder cancer	6.96e-05	0.000353	CcSEcCtD
Indinavir—Vomiting—Methotrexate—urinary bladder cancer	6.93e-05	0.000352	CcSEcCtD
Indinavir—Rash—Methotrexate—urinary bladder cancer	6.88e-05	0.000349	CcSEcCtD
Indinavir—Dermatitis—Methotrexate—urinary bladder cancer	6.87e-05	0.000349	CcSEcCtD
Indinavir—Headache—Methotrexate—urinary bladder cancer	6.83e-05	0.000347	CcSEcCtD
Indinavir—Asthenia—Doxorubicin—urinary bladder cancer	6.77e-05	0.000344	CcSEcCtD
Indinavir—Dizziness—Epirubicin—urinary bladder cancer	6.75e-05	0.000343	CcSEcCtD
Indinavir—Pruritus—Doxorubicin—urinary bladder cancer	6.68e-05	0.000339	CcSEcCtD
Indinavir—Vomiting—Epirubicin—urinary bladder cancer	6.49e-05	0.000329	CcSEcCtD
Indinavir—Nausea—Methotrexate—urinary bladder cancer	6.48e-05	0.000329	CcSEcCtD
Indinavir—Diarrhoea—Doxorubicin—urinary bladder cancer	6.46e-05	0.000328	CcSEcCtD
Indinavir—Rash—Epirubicin—urinary bladder cancer	6.43e-05	0.000327	CcSEcCtD
Indinavir—Dermatitis—Epirubicin—urinary bladder cancer	6.43e-05	0.000326	CcSEcCtD
Indinavir—Headache—Epirubicin—urinary bladder cancer	6.39e-05	0.000325	CcSEcCtD
Indinavir—Dizziness—Doxorubicin—urinary bladder cancer	6.24e-05	0.000317	CcSEcCtD
Indinavir—Nausea—Epirubicin—urinary bladder cancer	6.06e-05	0.000308	CcSEcCtD
Indinavir—Vomiting—Doxorubicin—urinary bladder cancer	6e-05	0.000305	CcSEcCtD
Indinavir—Rash—Doxorubicin—urinary bladder cancer	5.95e-05	0.000302	CcSEcCtD
Indinavir—Dermatitis—Doxorubicin—urinary bladder cancer	5.95e-05	0.000302	CcSEcCtD
Indinavir—Headache—Doxorubicin—urinary bladder cancer	5.91e-05	0.0003	CcSEcCtD
Indinavir—Nausea—Doxorubicin—urinary bladder cancer	5.61e-05	0.000285	CcSEcCtD
Indinavir—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	2.71e-05	0.000316	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.71e-05	0.000316	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	2.71e-05	0.000315	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	2.7e-05	0.000315	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	2.68e-05	0.000312	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.68e-05	0.000312	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.64e-05	0.000308	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—HPGDS—urinary bladder cancer	2.6e-05	0.000303	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ENO2—urinary bladder cancer	2.6e-05	0.000303	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—NQO1—urinary bladder cancer	2.59e-05	0.000301	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.58e-05	0.000301	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	2.55e-05	0.000298	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	2.53e-05	0.000295	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—NAT2—urinary bladder cancer	2.53e-05	0.000295	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GSTT1—urinary bladder cancer	2.53e-05	0.000294	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.51e-05	0.000292	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.5e-05	0.000291	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.49e-05	0.000291	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	2.49e-05	0.00029	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	2.47e-05	0.000287	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	2.46e-05	0.000286	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.43e-05	0.000283	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	2.4e-05	0.000279	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.38e-05	0.000278	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.38e-05	0.000277	CbGpPWpGaD
Indinavir—ABCC1—Disease—NCOR1—urinary bladder cancer	2.37e-05	0.000276	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.37e-05	0.000276	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.32e-05	0.00027	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.31e-05	0.000269	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.27e-05	0.000264	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—NQO1—urinary bladder cancer	2.26e-05	0.000263	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	2.23e-05	0.00026	CbGpPWpGaD
Indinavir—ABCC1—Disease—ERCC2—urinary bladder cancer	2.23e-05	0.000259	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	2.2e-05	0.000257	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	2.2e-05	0.000257	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.19e-05	0.000255	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—RRM2—urinary bladder cancer	2.18e-05	0.000255	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.17e-05	0.000253	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.16e-05	0.000252	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GSTP1—urinary bladder cancer	2.16e-05	0.000251	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.15e-05	0.00025	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.15e-05	0.00025	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.11e-05	0.000246	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	2.11e-05	0.000246	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—NQO1—urinary bladder cancer	2.1e-05	0.000245	CbGpPWpGaD
Indinavir—ABCC1—Disease—MTHFR—urinary bladder cancer	2.09e-05	0.000244	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.09e-05	0.000243	CbGpPWpGaD
Indinavir—ABCC1—Disease—TERT—urinary bladder cancer	2.09e-05	0.000243	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.08e-05	0.000242	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.08e-05	0.000242	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.07e-05	0.000241	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	2.07e-05	0.000241	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—HRAS—urinary bladder cancer	2.05e-05	0.000239	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	2.05e-05	0.000239	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.03e-05	0.000236	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.02e-05	0.000236	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.02e-05	0.000236	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—TYMS—urinary bladder cancer	2.01e-05	0.000234	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.99e-05	0.000232	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.98e-05	0.000231	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GSTM1—urinary bladder cancer	1.98e-05	0.000231	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—NCOR1—urinary bladder cancer	1.98e-05	0.000231	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.98e-05	0.00023	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.97e-05	0.00023	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.96e-05	0.000229	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.96e-05	0.000229	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.96e-05	0.000228	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	1.95e-05	0.000227	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.93e-05	0.000225	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.91e-05	0.000223	CbGpPWpGaD
Indinavir—ABCC1—Disease—FGFR3—urinary bladder cancer	1.91e-05	0.000223	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.91e-05	0.000222	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	1.91e-05	0.000222	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GPX1—urinary bladder cancer	1.9e-05	0.000221	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.89e-05	0.000221	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	1.88e-05	0.000219	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	1.88e-05	0.000219	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.88e-05	0.000219	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ERCC2—urinary bladder cancer	1.86e-05	0.000217	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	1.8e-05	0.00021	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.8e-05	0.00021	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.78e-05	0.000208	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.77e-05	0.000206	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.77e-05	0.000206	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—MTHFR—urinary bladder cancer	1.75e-05	0.000204	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	1.75e-05	0.000204	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.75e-05	0.000204	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.73e-05	0.000201	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.73e-05	0.000201	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.7e-05	0.000198	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.69e-05	0.000197	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.67e-05	0.000195	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.66e-05	0.000194	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.66e-05	0.000193	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.65e-05	0.000192	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.63e-05	0.00019	CbGpPWpGaD
Indinavir—ABCC1—Disease—CREBBP—urinary bladder cancer	1.63e-05	0.00019	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—TYMS—urinary bladder cancer	1.63e-05	0.00019	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.63e-05	0.00019	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.63e-05	0.000189	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	1.61e-05	0.000187	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	1.61e-05	0.000187	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.58e-05	0.000184	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.56e-05	0.000182	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.56e-05	0.000182	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.55e-05	0.000181	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.55e-05	0.000181	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GPX1—urinary bladder cancer	1.54e-05	0.00018	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.54e-05	0.000179	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.53e-05	0.000178	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.53e-05	0.000178	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.53e-05	0.000178	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.52e-05	0.000177	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.52e-05	0.000177	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	1.51e-05	0.000176	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.49e-05	0.000174	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.48e-05	0.000173	CbGpPWpGaD
Indinavir—ABCC1—Disease—RHOA—urinary bladder cancer	1.47e-05	0.000172	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.44e-05	0.000168	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.44e-05	0.000168	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.43e-05	0.000166	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.43e-05	0.000166	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	1.42e-05	0.000166	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PPARG—urinary bladder cancer	1.42e-05	0.000166	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.42e-05	0.000165	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.4e-05	0.000163	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.39e-05	0.000162	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.38e-05	0.000161	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CREBBP—urinary bladder cancer	1.36e-05	0.000159	CbGpPWpGaD
Indinavir—ABCC1—Disease—ERBB2—urinary bladder cancer	1.36e-05	0.000159	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.36e-05	0.000159	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.36e-05	0.000158	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	1.35e-05	0.000157	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTGS2—urinary bladder cancer	1.33e-05	0.000155	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.3e-05	0.000152	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	1.3e-05	0.000151	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.26e-05	0.000147	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.26e-05	0.000147	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.25e-05	0.000146	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.25e-05	0.000146	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.24e-05	0.000145	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.24e-05	0.000144	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.23e-05	0.000143	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.22e-05	0.000143	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.2e-05	0.000139	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.19e-05	0.000139	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.18e-05	0.000137	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	0.000137	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN1A—urinary bladder cancer	1.17e-05	0.000136	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTEN—urinary bladder cancer	1.16e-05	0.000136	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.16e-05	0.000135	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PPARG—urinary bladder cancer	1.15e-05	0.000134	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.15e-05	0.000134	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTGS2—urinary bladder cancer	1.12e-05	0.00013	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.12e-05	0.00013	CbGpPWpGaD
Indinavir—ABCC1—Disease—EP300—urinary bladder cancer	1.11e-05	0.000129	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	1.11e-05	0.000129	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.1e-05	0.000129	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.08e-05	0.000126	CbGpPWpGaD
Indinavir—ABCC1—Disease—SRC—urinary bladder cancer	1.08e-05	0.000126	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.07e-05	0.000124	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	1.06e-05	0.000124	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.05e-05	0.000123	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.03e-05	0.00012	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.03e-05	0.00012	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.02e-05	0.000119	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.02e-05	0.000118	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—TYMS—urinary bladder cancer	9.78e-06	0.000114	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	9.75e-06	0.000114	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTEN—urinary bladder cancer	9.75e-06	0.000114	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.73e-06	0.000113	CbGpPWpGaD
Indinavir—ABCC1—Disease—MYC—urinary bladder cancer	9.67e-06	0.000113	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	9.67e-06	0.000113	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	9.66e-06	0.000113	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	9.66e-06	0.000113	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	9.59e-06	0.000112	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—TYMS—urinary bladder cancer	9.54e-06	0.000111	CbGpPWpGaD
Indinavir—ABCC1—Disease—EGFR—urinary bladder cancer	9.46e-06	0.00011	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NCOR1—urinary bladder cancer	9.43e-06	0.00011	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTM1—urinary bladder cancer	9.43e-06	0.00011	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	9.41e-06	0.00011	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ENO2—urinary bladder cancer	9.41e-06	0.00011	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—EP300—urinary bladder cancer	9.3e-06	0.000108	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.28e-06	0.000108	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	9.26e-06	0.000108	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GPX1—urinary bladder cancer	9.25e-06	0.000108	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.12e-06	0.000106	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	9.09e-06	0.000106	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	9.07e-06	0.000106	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.03e-06	0.000105	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—TYMS—urinary bladder cancer	8.99e-06	0.000105	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPARG—urinary bladder cancer	8.96e-06	0.000104	CbGpPWpGaD
Indinavir—ABCC1—Disease—KRAS—urinary bladder cancer	8.94e-06	0.000104	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—TYMS—urinary bladder cancer	8.91e-06	0.000104	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	8.89e-06	0.000104	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	8.89e-06	0.000104	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ERCC2—urinary bladder cancer	8.87e-06	0.000103	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—EP300—urinary bladder cancer	8.83e-06	0.000103	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	8.81e-06	0.000103	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	8.81e-06	0.000103	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	8.6e-06	0.0001	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	8.54e-06	9.95e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GPX1—urinary bladder cancer	8.51e-06	9.92e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTEN—urinary bladder cancer	8.5e-06	9.9e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GPX1—urinary bladder cancer	8.44e-06	9.83e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	8.36e-06	9.74e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.34e-06	9.71e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	8.28e-06	9.65e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—EP300—urinary bladder cancer	8.11e-06	9.45e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTEN—urinary bladder cancer	7.91e-06	9.22e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	7.85e-06	9.15e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	7.79e-06	9.07e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—HRAS—urinary bladder cancer	7.6e-06	8.85e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NQO1—urinary bladder cancer	7.58e-06	8.83e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—EP300—urinary bladder cancer	7.54e-06	8.79e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	7.05e-06	8.21e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARG—urinary bladder cancer	6.92e-06	8.07e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARG—urinary bladder cancer	6.76e-06	7.87e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	6.65e-06	7.75e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.49e-06	7.56e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARG—urinary bladder cancer	6.37e-06	7.42e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.32e-06	7.37e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARG—urinary bladder cancer	6.31e-06	7.36e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTEN—urinary bladder cancer	6.15e-06	7.16e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	6.12e-06	7.13e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	6.07e-06	7.07e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.88e-06	6.85e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—EP300—urinary bladder cancer	5.86e-06	6.83e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.81e-06	6.77e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.81e-06	6.77e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.56e-06	6.48e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.46e-06	6.37e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	5.45e-06	6.35e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.32e-06	6.19e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.14e-06	5.98e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	5.01e-06	5.84e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	4.97e-06	5.79e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTEN—urinary bladder cancer	4.75e-06	5.53e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.64e-06	5.4e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—EP300—urinary bladder cancer	4.53e-06	5.28e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—EP300—urinary bladder cancer	4.42e-06	5.15e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTEN—urinary bladder cancer	4.37e-06	5.09e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTEN—urinary bladder cancer	4.33e-06	5.05e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—EP300—urinary bladder cancer	4.17e-06	4.86e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.16e-06	4.85e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—EP300—urinary bladder cancer	4.13e-06	4.81e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4e-06	4.66e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.28e-06	3.82e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.86e-06	3.33e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.72e-06	3.17e-05	CbGpPWpGaD
